Merck Other Non-Current Liabilities 2010-2024 | MRK

Merck other non-current liabilities for the quarter ending September 30, 2024 were $7.540B, a 2.68% increase year-over-year.

  • Merck other non-current liabilities for 2023 were $8.792B, a 5.63% increase from 2022.
  • Merck other non-current liabilities for 2022 were $8.323B, a 11.78% decline from 2021.
  • Merck other non-current liabilities for 2021 were $9.434B, a 23.34% decline from 2020.

Merck Other Non-Current Liabilities 2010-2024 | MRK

  • Merck other non-current liabilities for 2023 were $8.792B, a 5.63% increase from 2022.
  • Merck other non-current liabilities for 2022 were $8.323B, a 11.78% decline from 2021.
  • Merck other non-current liabilities for 2021 were $9.434B, a 23.34% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B